Cataplasm-based controlled drug delivery: Development and optimization of a novel formulation

Drug Development and Industrial Pharmacy

Volumn 25, Issue 5, 1999, Pages 659-665

  Agarwal, Vikas ^a,b   Singh, Shailesh K ^c   Reddy, Indra K ^b   Durrani, Manzer J ^d   Khan, Mansoor A ^a,b  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF LOUISIANA AT MONROE   (United States)

^c PFIZER INC   (United States)

^d GENZYME CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG VEHICLE; IBUPROFEN; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ARTICLE; CATAPLASM; DISPERSION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; DRUG RELEASE; DRUG STABILITY; DRUG SYNTHESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

ADHESIVES; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHEMISTRY, PHARMACEUTICAL; DRUG DELIVERY SYSTEMS; GLYCEROL; IBUPROFEN; POLYVINYLS;

EID: 0032890596     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.1081/DDC-100102222     Document Type: Article

References (9)

1. M. Rosenthal and I. Bahous, Drugs Exp. Clin. Res., 19, 99-105 (1993).
2. M. Galeazzi and R. Marcolongo, Drugs Exp. Clin. Res., 19, 107-115 (1993).
3. R. L. Dreiser and M. T. Camus, Drugs Exp. Clin. Res., 19, 117-123 (1993).
4. P. Jenoure, B. Segesser, U. Luhti, and G. Gremion, Drugs Exp. Clin. Res., 19, 125-131 (1993).
5. H. Sasaki, Y. Nakumara, J. Shiba, Y. Ishino, K. Miyasato, and T. Ashizawa, Chem. Pharm. Bull., 35, 4883-4890 (1987).
6. W. Bialik, K. A. Walters, K. R. Brain, and J. Hadcraft, Int. J. Pharm., 92, 219-223 (1993).
7. S. W. Kim, Y. H. Bae, and T. Okano, Pharm. Res., 9, 283-289 (1992).
8. X-Stat, Version 2.0, Wiley, New York, 1993.
9. S. V. Sastry, I. K. Reddy, and M. A. Khan, J. Controlled Release, 45, 121-130 (1997).